Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001000080 | SCV000654792 | likely benign | Immunodeficiency, common variable, 10 | 2024-01-19 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001000080 | SCV000884255 | likely benign | Immunodeficiency, common variable, 10 | 2018-09-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003424140 | SCV004127270 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | NFKB2: BS1, BS2 |
Center for Genomic Medicine, |
RCV003493641 | SCV004243387 | uncertain significance | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003952857 | SCV004767168 | likely benign | NFKB2-related disorder | 2022-02-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |